Le Lézard
Classified in: Science and technology, Business
Subjects: AWD, SCZ, DEI

LeafHouse is Recognized by DALBAR for Providing Exceptional Investment Management Services to Retirement Plans


LeafHouse Financial Earns DALBAR Honors for 5th Straight Year

MARLBOROUGH, Mass., July 21, 2022 /PRNewswire/ -- LeafHouse Financial, an independent, discretionary investment manager to the retirement industry was recently awarded DALBAR's 3(38) Certification. The Certification evaluates the qualifications, capabilities and services provided by an investment manager to determine if they meet the requirements of the Employee Retirement Income Security Act ("ERISA") section 3(38), that permits qualified investment managers to be appointed as fiduciaries to manage assets of retirement plans.

"We are pleased to complete the DALBAR Certification for the 5th year in a row. LeafHouse aims to help advisors and plan sponsors make an informed decision when hiring us as a 3(38) investment manager. DALBAR is an unbiased leader in these types of certifications for the financial community", says Dallas Villarreal, LeafHouse CCO & Sr. Operations Manager.

Evaluations consist of background checks of all key personnel, evaluation of potential conflicts of interest, reasonableness of arrangements and contracts, scope of work performed, adequacy of insurance protection and use of generally accepted investment theory.

LeafHouse Financial is an experienced, national discretionary investment manager and consultant for all types of retirement plans. LeafHouse acts in both a 3(21) and 3(38) fiduciary capacity for a multitude of private and public retirement plans that range from start-up to large institutions across the U.S. LeafHouse manages $15,453,585,811 as of December 31, 2021. LeafHouse developed proprietary technology that is designed to prudently select, evaluate, and monitor investments that are solely in the best interests of plan participants and their beneficiaries.

The firm is an independent and flexible fiduciary that aims to provide the maximum level of protection at a low cost to avoid conflicts of interest. LeafHouse integrates technology and industry knowledge aiming to provide a layer of protection to plan sponsors. As we work to uphold the fiduciary standard, our aim is to wholly align our interests with those of our clients.

LeafHouse is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration does not imply a certain level of skill or training. More information about LeafHouse's investment advisory services can be found in its Form ADV Part 2, which is available upon request.

SOURCE DALBAR, Inc.


These press releases may also interest you

at 08:15
VRGL, a Client Acquisition and Investment Proposal Management solution, today announced the launch of its new Risk Tolerance capabilities integrated within the existing VRGL workflow. VRGL's Risk Tolerance capabilities allow advisors to leverage a...

at 08:15
QPS, a leading global contract research organization (CRO), continues to expand and align its full-service preclinical, bioanalysis, and clinical capabilities with the evolution of demand for clinical trials. Today, QPS announced the expansion of its...

at 08:15
HCL Group, a global conglomerate, and UpLink, the open innovation platform of the World Economic Forum, announced the third challenge of the Aquapreneur Innovation Initiative, the "Tackling Water Pollution Challenge." This announcement was made...

at 08:15
Kalray (Euronext Growth Paris: ALKAL), a technology innovator building software and hardware solutions that accelerate data-intensive workflows, announced Ngenea® for AI, a new edition of its Kalray Data Acceleration Platform specifically fine-tuned...

at 08:15
Ransomware attacks on healthcare providers pose a significant threat to patient care and data security. According to Software Advice's 2024 Medical Cybersecurity Survey, more than 25% of ransomware attacks directly impact patient care, leading to...

at 08:15
Guardant Health, Inc. , a leading precision oncology company, today announced certification for its Guardant360® CDx blood test under the European Union's In Vitro Diagnostic Regulation (IVDR 2017/746). The certification from TÜV SÜD Product Service...



News published on and distributed by: